
Search documents
建筑材料行业跟踪周报:服务消费再贷款落地-20250512
Soochow Securities· 2025-05-12 14:36
证券研究报告·行业跟踪周报·建筑材料 建筑材料行业跟踪周报 服务消费再贷款落地 2025 年 05 月 12 日 增持(维持) [Table_Tag] [Table_Summary] 投资要点 ◼ 周观点:(1)央行落实此前刺激政策,创设 5000 亿服务消费和养老再 贷款,激励引导金融机构加大对住宿餐饮、文体娱乐、教育等服务消费 重点领域和养老产业的金融支持。4 月 CPI 相对平稳,PPI 下行压力加 大,但 4 月房企拿地情况有所好转,整体而言,地产链复苏的方向不变。 在以旧换新补贴和服务消费刺激政策的推动下,我们期待 25 年 Q3 家 装产业链也会迎来明显加速。地产链出清已近尾声,供给格局大幅改善, 25 年需求平稳且企业增长预期较低,板块具备较高的胜率。首选低估值 的消费龙头和扩张型公司,例如北新建材、三棵树、兔宝宝、奥普科技、 欧普照明、伟星新材、欧派家居、箭牌家居等。其次,如果外部需求快 速回落,中西部基建很有可能成为救急的方向,关注华新水泥、四川路 桥、海螺水泥、中国交建、坚朗五金、东方雨虹等。最后,在 25 年流 动性充裕的背景下,科技属性强的公司仍有较高关注度,例如上海港湾、 鸿路钢构、 ...
环保行业跟踪周报:侨银股份推进人形机器人城服应用,固废板块提分红验证+供热IDC拓展提ROE
Soochow Securities· 2025-05-12 10:23
执业证书:S0600511080001 021-60199782 yuanl@dwzq.com.cn 证券研究报告·行业跟踪周报·环保 环保行业跟踪周报 侨银股份推进人形机器人城服应用,固废板 块提分红验证+供热 IDC 拓展提 ROE 增持(维持) [Table_Tag] [投资要点 Table_Summary] 风险提示:政策推广不及预期,财政支出低于预期,行业竞争加剧。 2025 年 05 月 12 日 证券分析师 袁理 证券分析师 陈孜文 执业证书:S0600523070006 chenzw@dwzq.com.cn 行业走势 -19% -15% -11% -7% -3% 1% 5% 9% 13% 2024/5/13 2024/9/10 2025/1/8 2025/5/8 环保 沪深300 相关研究 《绿色动力 25Q1 业绩超预期,固废 板块提分红+提 ROE 核心逻辑验证》 2025-04-28 《政策明确碳市场扩容节奏,持续关 注稳健运营&自主可控&再生资源主 2025-04-22 东吴证券研究所 1 / 26 请务必阅读正文之后的免责声明部分 线 》 重点推荐:瀚蓝环境,绿色动力,永兴股份,光大 ...
宏观点评20250512:关税超预期下调,股债市场怎么走?-20250512
Soochow Securities· 2025-05-12 10:03
证券研究报告·宏观报告·宏观点评 宏观点评 20250512 关税超预期下调,股债市场怎么走? 2025 年 05 月 12 日 [Table_Tag] [Table_Summary] 事件 观点 ◼ 关税调降后,权益市场如何演绎? 4 月底以来,政治局会议召开定调全年经济政策措施,A 股上市公司 2024 年年报和 2025 年一季报业绩基本披露完毕,5 月初"一行一局一会"召开 金融政策发布会后,主要指数在关税冲下产生的缺口基本已经回补完毕。 5 月 7 日发布谈判消息至今日发布联合声明后,市场情绪将在短期内快速 演绎拉升,风险偏好上行利好前期跌幅较多的出口链继续回补,情绪层面 上科技板块会受到风险偏好的提升加速演绎。 由于市场对关税缓和已有预期,超预期下降幅度的消化时间可能在 1-2 天 内结束,后续的市场关注重点不再集中于海外变化,更倾向于国内的经济 基本面状况。当前,随着关税政策的缓和,后续的出口数据有望延续高增, 在其他托底政策的支持下,二季度有可能经济数据仍然能维持不错的增 长,因此,市场对国内政策的预期可能有所下降,导致估值已有修复的市 场再次进入到重新选择方向的轮动环境中,五月市场在利好落地 ...
晶泰控股:AIforScience稀缺标的,颠覆研发范式打开巨大市场空间-20250512
Soochow Securities· 2025-05-12 07:45
Investment Rating - The report assigns a "Buy" rating for the company, marking its first coverage [1]. Core Insights - The company is positioned as a rare asset in the AI for Science sector, aiming to disrupt traditional R&D paradigms and unlock significant market potential [1][14]. - The company has achieved a revenue milestone that qualifies it for commercial status on the Hong Kong Stock Exchange, with a projected revenue growth of 52.75% year-on-year in 2024 [8][14]. - The company is leveraging a strong scientific team, including over 500 scientists, to build a robust data moat and enhance its R&D capabilities [8][14]. Summary by Sections 1. AI for Science as a Rare Asset - The company was founded in 2015 and integrates quantum physics with AI and robotics to provide innovative R&D solutions in pharmaceuticals and materials science [14]. - It has attracted significant investment, raising approximately $732 million, and ranks first among AI-enabled drug discovery companies globally as of December 31, 2023 [17][19]. 2. AI Solutions and Automation Industry - The AI solutions market is expected to grow significantly, particularly in healthcare and materials science, driven by the need for efficient data processing and decision-making [26][30]. - The global automation market is rapidly expanding, with laboratory automation penetration projected to rise from 3.7% in 2022 to 23.2% by 2030 [27][30]. 3. Revenue and Profitability Forecast - The company forecasts revenues of 426.13 million RMB in 2025, 682.64 million RMB in 2026, and 1,095.22 million RMB in 2027, with a projected return to profitability in 2027 [1][8]. - The adjusted net loss is expected to narrow significantly, from 1.52 billion RMB in 2024 to a profit of 42.31 million RMB in 2027 [1][8]. 4. Data and Technological Moat - The company has built a comprehensive data infrastructure, including over 6.5 million high-precision quantitative data points and 100,000 molecular force field parameters, creating a significant barrier to entry [8][14]. - The integration of AI and robotics in its operations allows for a closed-loop system in both dry and wet experiments, enhancing efficiency and data generation [8][14]. 5. Collaborative Pipeline and Market Expansion - The company is advancing multiple collaborative drug pipelines, including a key product in clinical trials for treating advanced solid tumors, and is expanding into new materials and sectors [8][14]. - A recent partnership with a major group is expected to contribute approximately 1 billion RMB to the company's revenue over five years [8][14].
环保行业跟踪周报:侨银股份推进人形机器人城服应用,固废板块提分红验证+供热IDC拓展提ROE-20250512
Soochow Securities· 2025-05-12 07:39
证券研究报告·行业跟踪周报·环保 环保行业跟踪周报 侨银股份推进人形机器人城服应用,固废板 块提分红验证+供热 IDC 拓展提 ROE 增持(维持) [Table_Tag] [投资要点 Table_Summary] 风险提示:政策推广不及预期,财政支出低于预期,行业竞争加剧。 2025 年 05 月 12 日 证券分析师 袁理 执业证书:S0600511080001 021-60199782 yuanl@dwzq.com.cn 证券分析师 陈孜文 执业证书:S0600523070006 chenzw@dwzq.com.cn 行业走势 -19% -15% -11% -7% -3% 1% 5% 9% 13% 2024/5/13 2024/9/10 2025/1/8 2025/5/8 环保 沪深300 相关研究 《绿色动力 25Q1 业绩超预期,固废 板块提分红+提 ROE 核心逻辑验证》 2025-04-28 《政策明确碳市场扩容节奏,持续关 注稳健运营&自主可控&再生资源主 2025-04-22 东吴证券研究所 1 / 26 请务必阅读正文之后的免责声明部分 线 》 重点推荐:瀚蓝环境,绿色动力,永兴股份,光大 ...
建筑装饰行业跟踪周报:增量政策持续出台,关注开工端实物量落地
Soochow Securities· 2025-05-12 07:25
证券研究报告·行业跟踪周报·建筑装饰 建筑装饰行业跟踪周报 增量政策持续出台,关注开工端实物量落 地 增持(维持) [Table_Tag] [投资要点 Table_Summary] (2)出海方向:2024 年我国对外承包工程业务完成营业额同比增长 3.1%,新签合同金额同比增长 1.1%,创历史新高,对外投资平稳发 展;近期美国加征关税以及贸易摩擦升级,后续外交博弈、贸易摩擦 或加剧,一带一路战略推进或加码,预期未来中欧合作、东盟地区合 作有望更加密切。近期习近平主席对越南、马来西亚和柬埔寨三国进 行了国事访问,达成了上百项合作成果,基建合作仍是重要形式,海 外工程需求景气度有望保持,海外工程业务有望受益,后续预计逐渐 兑现到订单和业绩层面。建议关注国际工程板块,个股推荐中材国 际、上海港湾,建议关注中工国际、北方国际、中钢国际等。 (3)需求结构有亮点,新业务增量开拓下的投资机会:部分专业制造 工程细分领域、装配式建筑、节能降碳以及新能源相关的基建细分领 域景气度较高,有相关转型布局的企业有望受益,建议关注装配式建 筑方向的鸿路钢构、华阳国际等;半导体洁净室景气度有望延续,关 注亚翔集成、柏诚股份等。 ◼ ...
晶泰控股(02228):AIforScience稀缺标的,颠覆研发范式打开巨大市场空间
Soochow Securities· 2025-05-12 06:54
Investment Rating - The report assigns a "Buy" rating for the company, marking its first coverage [1]. Core Viewpoints - The company is positioned as a rare asset in the AI for Science sector, aiming to disrupt traditional R&D paradigms and unlock significant market potential [1][14]. - The company has achieved a revenue milestone that qualifies it as a commercial entity under Hong Kong Stock Exchange rules, with a notable reduction in net losses [8][14]. - The integration of dry and wet lab experiments creates a data barrier that strengthens the company's competitive moat [8][14]. - The company is making progress in its collaborative drug pipeline and expanding its client base in new materials and other sectors [8][14]. - Short-term growth is driven by policy incentives, while long-term growth is supported by customer retention and successful project incubation [8][14]. Summary by Sections 1. AI for Science as a Rare Asset - The company, founded in 2015, leverages quantum physics and AI to provide innovative R&D solutions across pharmaceuticals and materials science [14]. - The founding team consists of MIT-trained scientists, enhancing the company's R&D capabilities [8][14]. - The company has raised approximately $732 million from global investors, establishing itself as a leader in AI-enabled drug discovery [17][19]. 2. AI Solutions and Automation Industry - The AI solutions market is expected to grow significantly, particularly in healthcare and materials science [26][30]. - The global automation market is rapidly expanding, with laboratory automation penetration projected to increase from 3.7% in 2022 to 23.2% by 2030 [27][30]. - The convergence of data growth, labor cost increases, and technological integration is driving the growth of AI solutions and automation [34]. 3. Revenue and Profitability Forecast - The company forecasts revenues of RMB 4.26 billion, RMB 6.83 billion, and RMB 10.95 billion for 2025, 2026, and 2027, respectively, with a projected return to profitability by 2027 [1][8]. - The adjusted net loss is expected to narrow significantly over the forecast period, indicating improving financial health [1][8]. 4. Market Trends and Opportunities - The AI drug discovery market is anticipated to grow from RMB 2.76 billion in 2022 to RMB 67.7 billion by 2025, driven by advancements in technology and increased collaboration [41][42]. - The solid-state R&D services market is projected to grow at a CAGR of 27.7%, reaching $20.9 billion by 2030 [52].
建筑装饰行业跟踪周报:增量政策持续出台,关注开工端实物量落地-20250512
Soochow Securities· 2025-05-12 06:35
证券研究报告·行业跟踪周报·建筑装饰 增量政策持续出台,关注开工端实物量落 地 增持(维持) [Table_Tag] [投资要点 Table_Summary] (2)出海方向:2024 年我国对外承包工程业务完成营业额同比增长 3.1%,新签合同金额同比增长 1.1%,创历史新高,对外投资平稳发 展;近期美国加征关税以及贸易摩擦升级,后续外交博弈、贸易摩擦 或加剧,一带一路战略推进或加码,预期未来中欧合作、东盟地区合 作有望更加密切。近期习近平主席对越南、马来西亚和柬埔寨三国进 行了国事访问,达成了上百项合作成果,基建合作仍是重要形式,海 外工程需求景气度有望保持,海外工程业务有望受益,后续预计逐渐 兑现到订单和业绩层面。建议关注国际工程板块,个股推荐中材国 际、上海港湾,建议关注中工国际、北方国际、中钢国际等。 (3)需求结构有亮点,新业务增量开拓下的投资机会:部分专业制造 工程细分领域、装配式建筑、节能降碳以及新能源相关的基建细分领 域景气度较高,有相关转型布局的企业有望受益,建议关注装配式建 筑方向的鸿路钢构、华阳国际等;半导体洁净室景气度有望延续,关 注亚翔集成、柏诚股份等。 ◼ 风险提示:地产信用风 ...
新动能驱动“科特估”为资本市场“排头兵”
Soochow Securities· 2025-05-12 06:06
证券研究报告·宏观报告·宏观深度报告 宏观深度报告 20250512 新动能驱动"科特估"为资本市场"排头兵" [Table_Summary] ◼ 新旧动能转换下,内需扩张迫在眉睫: 关税战是一场遭遇战、持久战,全球需求承压:"遭遇战"之下,各国 的应对方式和手段在贸易战后期的很长一段时间内都将影响各自经济 增长的实际走向。中美的"大国之争"在美国内在经济问题和全球经济 增长问题暂未得到明显缓解之前仍将持续,"关税战"可能将是一场"持 久战",作为以打促谈的手段,关税的议题可能将贯穿较长的时间周期。 关税战不仅是短期的贸易摩擦,更对全球经济结构造成深远影响,进一 步抑制全球投资与消费需求。 科技产业经济占比提升,经济新动能打开内需新市场:截至 2024 年底, 数字经济核心产业增加值占国内生产总值比重 10%左右。2022 年,中 国的 KTI 制造业产出比 2012 年翻了一倍多,全球份额从 2012 年的 22% 增至 2022 年的 34%。数字经济技术应用和数字产品制造是引领当前经 济发展的主要方向,也是激发内需潜力、驱动产业创新、塑造发展新优 势的主要抓手,而科技相关服务业目前占比相对低,与海外主流 ...
项目投资由基建地产转向科创:地方国企债券融资都去哪了?
Soochow Securities· 2025-05-12 05:42
证券研究报告·宏观报告·宏观深度报告 宏观深度报告 20250512 地方国企债券融资都去哪了? ——项目投资由基建地产转向科创 2025 年 05 月 12 日 证券分析师 芦哲 执业证书:S0600524110003 luzhe@dwzq.com.cn 证券分析师 刘子博 执业证书:S0600524120014 liuzb@dwzq.com.cn 相关研究 《美国 4 月 CPI 前瞻:开始验收关税 冲击幅度》 2025-05-11 《特别国债发行前置或推升 4 月社融 增速》 2025-05-11 东吴证券研究所 1 / 10 请务必阅读正文之后的免责声明部分 [Table_Tag] [Table_Summary] ◼ 2024 年我国地方国资委监管企业完成固定资产投资 7 万亿元,同比增 长 4.2%,增速高于全国平均水平 1 个百分点。面对日趋复杂的国内外 经济环境,2025 年多省国资委发文强调属地国企要继续发挥经济增长 的压舱石作用。因此,我们通过拆解 6044 只 2025 年 1-4 月及上年同期 地方国企公募发行信用债的募集资金用途,归纳总结地方国企投资的重 点投向变化。 ◼ 一、地方国企 ...